COMMON WARTS
Clinical trials for COMMON WARTS explained in plain language.
Never miss a new study
Get alerted when new COMMON WARTS trials appear
Sign up with your email to follow new studies for COMMON WARTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gel could zap away common warts
Disease control Recruiting nowThis study tests a gel called YCANTH on common warts caused by HPV. About 300 people aged 2 and older will apply the gel to their warts to see if it clears them completely by day 84. The goal is to find a safe and effective treatment for warts on the body.
Matched conditions: COMMON WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
New hope for stubborn warts: extended treatment shows promise
Disease control Recruiting nowThis study follows people who already took part in earlier trials for common warts. They can receive up to 4 more treatments with YCANTH, a liquid applied to each wart every 21 days. The goal is to see if the treatment is safe and can clear all warts over about a year. Around 600…
Matched conditions: COMMON WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 04:08 UTC
-
Pain-free wart cream for kids shows promise in new study
Symptom relief Recruiting nowThis study tests a cream made of two medicines (5-fluorouracil and calcipotriol) on children aged 4 to 18 with warts on their hands or feet. The goal is to see if the cream can clear warts without the pain of freezing or other treatments. About 60 children will take part, and the…
Matched conditions: COMMON WARTS
Phase: NA • Sponsor: Mazandaran University of Medical Sciences • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC